ADMA and SDMA: What These Blood Vessel Markers Mean

Written by Dr. Ryan Kneessi, ND

Quick answer: ADMA and SDMA are natural byproducts of protein turnover. ADMA competes with arginine and can slow the production of nitric oxide, which helps blood vessels relax, while SDMA is cleared mainly by the kidneys and is often read as a kidney-related signal. Higher ADMA has been associated with more cardiovascular events, while the link for SDMA is less clear.

What do ADMA and SDMA on a cardio panel actually have to do with your blood vessels? Both are natural byproducts of protein turnover. ADMA, or asymmetric dimethylarginine, competes with arginine and can slow the body’s production of nitric oxide, the molecule that helps blood vessel linings relax and stay flexible. SDMA is its close cousin, does not block nitric oxide in the same way, and is cleared mainly by the kidneys, so it is often read as a kidney-related signal. A 2015 meta-analysis of 22 prospective studies found that people in the highest third of ADMA had more cardiovascular events than those in the lowest third, while the link for SDMA was less clear. Habits commonly discussed for healthy blood vessel function include regular aerobic movement, not smoking, a diet rich in vegetables, and good blood pressure and blood sugar habits. Nutrients often discussed include L-arginine, L-citrulline and folate.

This article is educational. It explains what the marker reflects and how researchers connect it to the deeper mechanisms of aging, so you can have a more informed conversation with your own provider.

How are ADMA and SDMA connected to aging and root causes?

ADMA and SDMA offer a look at one of the most important molecules for healthy blood vessels, which is nitric oxide. The lining of our arteries, called the endothelium, makes nitric oxide to help vessels relax, regulate blood flow and keep the surface smooth and resistant to clotting. ADMA competes with arginine at the enzyme that makes nitric oxide, so higher ADMA can mean less nitric oxide available to the vessel wall. SDMA is a close relative that does not block that enzyme in the same way and is cleared mostly by the kidneys.

In aging biology, endothelial health connects to several mechanisms. Reduced nitric oxide signaling is a form of altered intercellular signaling, since it changes how the vessel lining communicates with the muscle around it and with circulating immune cells. Lower nitric oxide is associated with more oxidative stress and chronic low-grade inflammation in the vessel wall. Research on endothelial cells has also explored links between impaired nitric oxide signaling and cellular senescence, but much of that work is still in laboratory models. Because ADMA is generated through the methylation pathway and is linked experimentally with homocysteine, epigenetic and methylation biology may be relevant as well, though the human evidence is early.

What can raise ADMA and SDMA?

Root-cause thinking looks upstream at what is stressing the endothelium. Smoking, high blood pressure, elevated blood sugar, unhealthy lipid patterns and sedentary living are among the most consistently discussed factors. Kidney function is especially important because both ADMA and SDMA are cleared partly through the kidneys, which is one reason SDMA is often read in that context. Nutrient status matters too, particularly folate and other B vitamins that support methylation, and genetic variation in the enzymes that break down ADMA can shape a person’s baseline. A 2015 meta-analysis in the Journal of the American Heart Association found that higher ADMA was associated with more cardiovascular events, while the evidence for SDMA was less clear.

What does the research show about ADMA and SDMA?

The Framingham Offspring Study measured ADMA in 3,320 adults with an average age of 59 and followed them for about 10.9 years. Each standard-deviation increase in ADMA was linked with a 21% higher risk of death (hazard ratio 1.21) after adjusting for many risk factors, and the link was strongest in people without diabetes. ADMA was measured once. (Böger et al., 2009)

A genetic study of more than 7,900 people from three population cohorts identified genes that control ADMA, arginine and SDMA, including a kidney gene that clears SDMA. In a stroke cohort, higher SDMA was linked with cardiometabolic risk factors, but the gene variants were not linked with stroke. The study focused on biology rather than outcomes. (Lüneburg et al., 2014)

Overall, ADMA has stronger outcome data than SDMA, which mainly tracks kidney function.

Related reading

If you would like to explore related topics, my articles on understanding cholesterol and lipids, blood pressure support and the hs-CRP inflammation test go deeper. You can also see the specialty tests I commonly recommend on my functional labs page.

Common questions about ADMA and SDMA

What is the difference between ADMA and SDMA?

ADMA competes with arginine at the enzyme that makes nitric oxide, so it relates most directly to blood vessel function. SDMA does not block that enzyme in the same way and is cleared mostly by the kidneys.

Why does kidney function matter for these markers?

Both ADMA and SDMA are cleared partly through the kidneys, so kidney function can shift both results. That is one reason they are best read in context.

Which habits are commonly discussed for blood vessel health?

Regular aerobic movement, not smoking, a diet rich in vegetables, and good blood pressure and blood sugar habits are commonly discussed.

Sources

This article is for educational purposes only and is not medical advice. It does not replace an individual evaluation. Talk with your healthcare provider before making changes to your diet, exercise, supplements, or medications, especially if you are pregnant, nursing, or managing a health condition.